Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on its optimism about the company's prophylactic treatment for Hereditary Angioedema...
   | No. | Hedge Fund | Shares | Value | Activity | % Port | 
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen  |  3,653,310 | $64,298,256 | 0.19% | |
| 2. | Deerfield Management James E. Flynn  |  2,017,464 | $35,507,366 | 0.64% | |
| 3. | Commodore Capital Egen Atkinson And Michael Kramarz  |  1,911,433 | $33,641,221 | 2.37% | |
| 4. | Cormorant Asset Management Bihua Chen  |  1,454,660 | $25,602,016 | -1% | 1.91% | 
| 5. | Soleus Capital Guy Levy  |  732,968 | $12,900,237 | -11% | 0.85% | 
| No. | Name | Shares | Value | % Port | 
|---|---|---|---|---|
| 1. | 5,800 | $144,710 | 0% |